The Certara Blog

Author: Michael Eckstut

Michael Eckstut is Senior Vice President and the Head of Certara Consulting. He joined Certara in 2014 from Archstone Consulting, a Hackett Group company, where he was head of the Life Sciences Practice and the Managing Partner of the firm’s West Region. Mr. Eckstut holds a BS and MS cum laude in Chemical Engineering from Rensselaer Polytechnic Institute and an MBA (as a Baker Scholar) from the Harvard Graduate School of Business Administration.

Recent Posts

Heartbreaking Works of Staggering Genius - Cardiac Safety for Oncology

Heartbreaking Works of Staggering Genius: Cardiac Safety for Oncology

I could give you some of facts and figures about cancer. Like the fact that the American Cancer Society estimates there will be 1,658,370 new cancer cases diagnosed and 589,430 cancer deaths in the US this year. Or that pancreatic cancer has only a 5-year survival rate of 5%. But, these statistics belie the heartbreaking reality […]

Read More
Fighting Superbugs - Supporting FDA Approval of a New Antibiotic

Fighting Superbugs: Supporting FDA Approval of a New Antibiotic

One of the most rewarding parts of leading Certara’s consulting services is recognizing how our work supports new drug approvals to positively impact patients’ health. In this blog post, I’ll discuss how Certara helped Cubist obtain FDA approval for Zerbaxa™ (ceftolozane/tazobactam), a new antibacterial drug to treat adults with complicated infections. The growing threat of […]

Read More